CIK 0001837607
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
AEON Biopharma, Inc.
Sign in to watch- Ticker
- AEON
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 853940478
- Phone
- +1 949-354-6499
- Business address
- 130 VANTIS DRIVE, SUITE 170, ALISO VIEJO, CA, 92656
- Former names
- Priveterra Acquisition Corp.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 60,000 shares at $0.49 ($29,250)
- 4 Open-market buy Director bought 110,000 shares at an average $0.50 ($55,300)
- 4 Grant or award President & CEO acquired 177,103 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4/A Grant or award Director acquired 36,021 shares (grant or award)
- 4 Grant or award CHIEF EXECTUIVE OFFICER acquired 470,692 shares (grant or award)
- 4 Grant or award EXEC VP, CLO & CORP SECRETARY acquired 180,110 shares (grant or award)
- 4 Grant or award Director acquired 36,021 shares (grant or award)
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 192,117 shares (grant or award)
- 4 Grant or award PRINCIPAL ACCOUNTING OFFICER acquired 18,010 shares (grant or award)
- 4 Grant or award Director acquired 36,021 shares (grant or award)
- 4 Grant or award Director acquired 36,021 shares (grant or award)
- 4 Grant or award Director acquired 36,021 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4/A Derivatives Options or other derivatives
Page 2 of 4 · 76 filings